Position: Commercial Director, Head of International (since 1 January 2026) 

Number of shares in Navamedic ASA:  13,422 

Current external directorships: Board member at PS Source AB, Alternate at Fredrik Vedin AB and EntreSec AB, Auditor for LÖK S80 (Landowner association) 

Year of birth:  1972 

Experience: Joined Navamedic in 2024 following the acquisition of Sensidose, where he served as Deputy CEO and COO. Slätis has 25 years of experience in the pharmaceutical industry, including senior commercial management roles at Sanofi, Baxalta and Baxter, commercial roles at SanofiPasteurMSD, NovoNordisk, Amgen and AstraZeneca and corporate leadership positions at Bluefish Pharmaceuticals and Unimedic Pharma. 

Education:  

BA and DipA from Stockholm University